Stellanova Therapeutics logo

Stellanova Therapeutics jobs and careers

About Stellanova Therapeutics

Stellanova Therapeutics is developing the first cancer therapies targeting cancer-associated fibroblasts (CAFs) and their symbiotic interactions within the tumor microenvironment.

Founded in 2019 by Ronald A. DePinho and Rosa F. Hwang.

Founded
2019
Employees
1 to 10
Total funding
$15.5M

Leadership

The top of Stellanova Therapeutics's org chart, with how many people report into each leader.

ESPhoto of Emmanuelle Schuler

Emmanuelle Schuler

Founding CEO

3 reports

JBPhoto of Juan Bournat

Juan Bournat

Research Scientist

1 report

SR

Stephen Rubino

Executive in Residence